{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:13:03Z","timestamp":1780751583547,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T00:00:00Z","timestamp":1546128000000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["1R34AA022055"],"award-info":[{"award-number":["1R34AA022055"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsat.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T14:16:31Z","timestamp":1494512191000},"page":"34-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-0400","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Chokron Garneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-8954","authenticated-orcid":false,"given":"Alexandra","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara A.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Glasner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2017.05.004_bb0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.15288\/jsad.2010.71.460","article-title":"Early adoption of injectable naltrexone for alcohol use disorders: Findings in the private treatment sector","volume":"71","author":"Abraham","year":"2010","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2017.05.004_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2015.10.003","article-title":"Extended-release naltrexone: A qualitative analysis of barriers to routine use","volume":"62","author":"Alanis-Hirsch","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2017.05.004_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00038-009-0095-x","article-title":"Alcohol consumption and risk of incident human immunodeficiency virus infection: A meta-analysis","volume":"55","author":"Baliunas","year":"2010","journal-title":"International Journal of Public Health"},{"issue":"Suppl. 8","key":"10.1016\/j.jsat.2017.05.004_bb0020","first-page":"S222","article-title":"Extended-release naltrexone for alcohol dependence: Persistence and healthcare costs and utilization","volume":"17","author":"Bryson","year":"2011","journal-title":"The American Journal of Managed Care"},{"key":"10.1016\/j.jsat.2017.05.004_bb0025","series-title":"2015 national survey on drug use and health: Detailed tables","author":"Center for Behavioral Health Statistics and Quality","year":"2016"},{"key":"10.1016\/j.jsat.2017.05.004_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2016.01.015","article-title":"HIV primary care providers\u2014Screening, knowledge, attitudes and behaviors related to alcohol interventions","volume":"161","author":"Chander","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2017.05.004_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/08897077.2012.763083","article-title":"Aversion to injection limits acceptability of extended-release naltrexone among homeless, alcohol-dependent patients","volume":"34","author":"Friedmann","year":"2013","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.05.004_bb0040","series-title":"Paper presented at the 123rd annual meeting of the American Psychological Association (Toronto, Canada)","article-title":"Development of a text messaging intervention for HIV+ alcohol users","author":"Glasner-Edwards","year":"2015"},{"issue":"2","key":"10.1016\/j.jsat.2017.05.004_bb0045","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.5407","article-title":"A cognitive behavioral therapy\u2013based text messaging intervention versus medical management for HIV-infected substance users: Study protocol for a pilot randomized Trial","volume":"5","author":"Glasner-Edwards","year":"2016","journal-title":"JMIR Research Protocols"},{"issue":"4","key":"10.1016\/j.jsat.2017.05.004_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1300\/J069v23n04_02","article-title":"Naltrexone and pharmacy benefit management","volume":"23","author":"Harris","year":"2004","journal-title":"Journal of Addictive Diseases"},{"issue":"5","key":"10.1016\/j.jsat.2017.05.004_bb0055","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/alcalc\/agw038","article-title":"Reductions in alcohol craving following naltrexone treatment for heavy drinking","volume":"51","author":"Helstrom","year":"2016","journal-title":"Alcohol and Alcoholism"},{"issue":"18","key":"10.1016\/j.jsat.2017.05.004_bb0060","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jsat.2017.05.004_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11121-006-0061-2","article-title":"Alcohol use and sexual risks for HIV\/AIDS in sub-Saharan Africa: Systematic review of empirical findings","volume":"8","author":"Kalichman","year":"2007","journal-title":"Prevention Science"},{"key":"10.1016\/j.jsat.2017.05.004_bb0070","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1360-0443.2008.02345.x","article-title":"Persistence with oral naltrexone for alcohol treatment: Implications for health-care utilization","volume":"103","author":"Kranzler","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2017.05.004_bb0075","series-title":"Content analysis: An introduction to its methodology","volume":"Vol. 5","author":"Krippendorff","year":"1980"},{"key":"10.1016\/j.jsat.2017.05.004_bb0080","series-title":"Continued use of addiction medications and impacts on use of health care","author":"McCarty","year":"2009"},{"issue":"26","key":"10.1016\/j.jsat.2017.05.004_bb0085","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1056\/NEJMsa022615","article-title":"The quality of health care delivered to adults in the United States","volume":"348","author":"McGlynn","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2017.05.004_bb0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11904-010-0059-z","article-title":"Drug treatment as HIV prevention: Expanding treatment options","volume":"7","author":"Metzger","year":"2010","journal-title":"Current HIV\/AIDS Reports"},{"issue":"8","key":"10.1016\/j.jsat.2017.05.004_bb0095","first-page":"1386","article-title":"Naltrexone's effect on cue-elicited craving among alcoholics in treatment","volume":"23","author":"Monti","year":"1999","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2017.05.004_bb0100","series-title":"Helping patients who drink too much: A clinician's guide (updated 2005 edition)","author":"NIAAA","year":"2015"},{"key":"10.1016\/j.jsat.2017.05.004_bb0105","series-title":"Answers to frequently asked medication questions","author":"NIAAA","year":"2017"},{"issue":"1","key":"10.1016\/j.jsat.2017.05.004_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002130100919","article-title":"Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo\u2013pituitary\u2013adrenocortical axis","volume":"160","author":"O'Malley","year":"2002","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2017.05.004_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187152710790966704","article-title":"Naltrexone for the treatment of alcoholism: Clinical findings, mechanisms of action, and pharmacogenetics","volume":"9","author":"Ray","year":"2010","journal-title":"CNS & Neurological Disorders - Drug Targets"},{"issue":"1","key":"10.1016\/j.jsat.2017.05.004_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1360-0443.2011.03621.x","article-title":"Alcohol consumption and the intention to engage in unprotected sex: Systematic review and meta-analysis of experimental studies","volume":"107","author":"Rehm","year":"2012","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.jsat.2017.05.004_bb0125","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","volume":"49","author":"Roux","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2017.05.004_bb0130","series-title":"National survey of substance abuse treatment services: 2013. Data on substance abuse treatment facilities","author":"SAMHSA","year":"2014"},{"key":"10.1016\/j.jsat.2017.05.004_bb0135","series-title":"Computer-aided qualitative data analysis: Theory, methods, and practice","first-page":"52","article-title":"Different functions of coding in the analysis of textual data","author":"Seidel","year":"1995"},{"issue":"2","key":"10.1016\/j.jsat.2017.05.004_bb0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/alcalc\/agp091","article-title":"Causal considerations on alcohol and HIV\/AIDS\u2014A systematic review","volume":"45","author":"Shuper","year":"2010","journal-title":"Alcohol and Alcoholism"},{"issue":"157","key":"10.1016\/j.jsat.2017.05.004_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2015.10.023","article-title":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","volume":"1","author":"Springer","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2017.05.004_bb0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0306-4603(01)00205-2","article-title":"Alcohol and HIV risk taking among intravenous drug users","volume":"27","author":"Stein","year":"2002","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2017.05.004_bb0155","article-title":"Treatment episode data set (TEDS): 2004-2014. National admissions to substance abuse treatment services","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality","year":"2016"},{"issue":"5","key":"10.1016\/j.jsat.2017.05.004_bb0160","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1360-0443.2010.02905.x","article-title":"Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users","volume":"105","author":"Uhlmann","year":"2010","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.jsat.2017.05.004_bb0165","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2017.05.004_bb0170","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1189\/jlb.1105642","article-title":"Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes","volume":"79","author":"Wang","year":"2006","journal-title":"Journal of Leukocyte Biology"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:54Z","timestamp":1760039274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216304172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"alternative-id":["S0740547216304172"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.05.004","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}